Literature DB >> 22108191

Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Mats B O Larsson1, Kirsten Tillisch, A D Craig, Maria Engström, Jennifer Labus, Bruce Naliboff, Peter Lundberg, Magnus Ström, Emeran A Mayer, Susanna A Walter.   

Abstract

BACKGROUND & AIMS: Only a fraction of patients with irritable bowel syndrome (IBS) have increased perceptual sensitivity to rectal distension, indicating differences in processing and/or modulation of visceral afferent signals. We investigated the brain mechanisms of these perceptual differences.
METHODS: We analyzed data from 44 women with IBS and 20 female healthy subjects (controls). IBS symptom severity was determined by a severity scoring system. Anxiety and depression symptoms were assessed using the hospital anxiety and depression score. Blood oxygen level-dependent signals were measured by functional magnetic resonance imaging during expectation and delivery of high (45 mmHg) and low (15 mmHg) intensity rectal distensions. Perception thresholds to rectal distension were determined in the scanner. Brain imaging data were compared among 18 normosensitive and 15 hypersensitive patients with IBS and 18 controls. Results were reported significant if peak P-values were ≤.05, with family-wise error correction in regions of interest.
RESULTS: The subgroups of patients with IBS were similar in age, symptom duration, psychological symptoms, and IBS symptom severity. Although brain responses to distension were similar between normosensitive patients and controls, hypersensitive patients with IBS had greater activation of insula and reduced deactivation in pregenual anterior cingulate cortex during noxious rectal distensions, compared to controls and normosensitive patients with IBS. During expectation of rectal distension, normosensitive patients with IBS had more activation in right hippocampus than controls.
CONCLUSIONS: Despite similarities in symptoms, hyper- and normosensitive patients with IBS differ in cerebral responses to standardized rectal distensions and their expectation, consistent with differences in ascending visceral afferent input. Copyright Â
© 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22108191      PMCID: PMC3288538          DOI: 10.1053/j.gastro.2011.11.022

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  57 in total

1.  Empathy for pain involves the affective but not sensory components of pain.

Authors:  Tania Singer; Ben Seymour; John O'Doherty; Holger Kaube; Raymond J Dolan; Chris D Frith
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

2.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

3.  Regional cerebral activity in normal and pathological perception of visceral pain.

Authors:  D H Silverman; J A Munakata; H Ennes; M A Mandelkern; C K Hoh; E A Mayer
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

4.  Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome.

Authors:  Elspeth Guthrie; Jo Barlow; Lakshmi Fernandes; Joy Ratcliffe; Nicholas Read; David G Thompson; Barbara Tomenson; Francis Creed
Journal:  Psychosom Med       Date:  2004 Jul-Aug       Impact factor: 4.312

5.  Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls.

Authors:  C H Wilder-Smith; D Schindler; K Lovblad; S M Redmond; A Nirkko
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

6.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

7.  The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.

Authors:  J S Labus; R Bolus; L Chang; I Wiklund; J Naesdal; E A Mayer; B D Naliboff
Journal:  Aliment Pharmacol Ther       Date:  2004-07-01       Impact factor: 8.171

8.  Upper gastrointestinal and mental symptoms in the irritable bowel syndrome.

Authors:  J Svedlund; I Sjödin; G Dotevall; R Gillberg
Journal:  Scand J Gastroenterol       Date:  1985-06       Impact factor: 2.423

9.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

Authors:  H Mertz; B Naliboff; J Munakata; N Niazi; E A Mayer
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

10.  Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI.

Authors:  Yao-Zong Yuan; Ran-Jun Tao; Bin Xu; Jing Sun; Ke-Min Chen; Fei Miao; Zhong-Wei Zhang; Jia-Yu Xu
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

View more
  73 in total

1.  Esophageal acid stimulation alters insular cortex functional connectivity in gastroesophageal reflux disease.

Authors:  R M Siwiec; A Babaei; M Kern; E A Samuel; S-J Li; R Shaker
Journal:  Neurogastroenterol Motil       Date:  2014-11-04       Impact factor: 3.598

Review 2.  Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Catherine S Hubbard; Joshua Bueller; Bahar Ebrat; Kirsten Tillisch; Michelle Chen; Jean Stains; George E Dukes; Dennis L Kelleher; Bruce D Naliboff; Michael Fanselow; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-08-14       Impact factor: 22.682

Review 3.  The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?

Authors:  Giada De Palma; Stephen M Collins; Premysl Bercik; Elena F Verdu
Journal:  J Physiol       Date:  2014-04-22       Impact factor: 5.182

4.  The medial temporal lobe in nociception: a meta-analytic and functional connectivity study.

Authors:  Lizbeth J Ayoub; Alexander Barnett; Aziliz Leboucher; Mitchell Golosky; Mary Pat McAndrews; David A Seminowicz; Massieh Moayedi
Journal:  Pain       Date:  2019-06       Impact factor: 6.961

Review 5.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

6.  Dyspepsia: Structural changes in functional gastrointestinal disorders.

Authors:  Emeran A Mayer; Kirsten Tillisch; Benjamin M Ellingson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

7.  Pilot Study of Functional Magnetic Resonance Imaging Responses to Somatic Pain Stimuli in Youth With Functional and Inflammatory Gastrointestinal Disease.

Authors:  Jeannie S Huang; Laura Terrones; Alan N Simmons; Walter Kaye; Irina Strigo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

8.  Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

Authors:  Ji-Meng Zhao; Jin-Hua Lu; Xiao-Jun Yin; Lu-Yi Wu; Chun-Hui Bao; Xing-Kui Chen; Yue-Hua Chen; Wei-Jun Tang; Xiao-Ming Jin; Huan-Gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

9.  Methodology for a trial of brain-centered versus anticholinergic therapy in women with urgency urinary incontinence.

Authors:  Yuko M Komesu; Rebecca G Rogers; Robert E Sapien; Ronald M Schrader; Timothy Simmerman-Sierra; Andrew R Mayer; Loren H Ketai
Journal:  Int Urogynecol J       Date:  2016-10-17       Impact factor: 2.894

Review 10.  Neuroanatomy of lower gastrointestinal pain disorders.

Authors:  Wim Vermeulen; Joris G De Man; Paul A Pelckmans; Benedicte Y De Winter
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.